Specific, effective, with a non-harmful and reversible action: the identikit of the ultimate biomaterial appears to match with graphene flakes.
Researchers from Cleveland Clinic's Global Center for Pathogen Research & Human Health have developed a promising new COVID-19 vaccine candidate that utilizes nanotechnology and has shown strong efficacy in preclinical disease models.
The Innovation Center of NanoMedicine (Director General: Prof. Kazunori Kataoka, Location: Kawasaki in Japan, Abbreviation: iCONM) reported in ACS Nano (Impact Factor: 14.588 in 2019) together with the group of Prof. Yu Matsumoto of Otorhinolaryngology and Head and Neck Surgery (Prof. Tatsuya Yamasoba) and the group of Prof. Horacio Cabral of the Department of Bioengineering (Prof. Ryo Miyake) in the University of Tokyo that the efficacy of polymeric nano-micelles with different drug activation profile depends on the expression level of c-Myc, one of the major proto-oncogene, has been developed.
Researchers still have a long path to tread before they can treat Alzheimer’s Disease, partially because the protein aggregates that can turn into brain plaques, a characteristic attribute of the disease, are challenging to analyze.
The genetic tool CRISPR has been likened to molecular scissors for its ability to snip out and replace genetic code within DNA.
Glioblastoma multiforme, the most common and aggressive form of primary brain tumor, has a survival rate of just five years. It is particularly challenging to treat, with existing therapies depending on chemotherapy, radiation, surgery, and their combinations.
Muscle plays a crucial role in maintaining the human lives and is the largest organ accounting for 40% of body mass.
Ever since X-rays were discovered by Wilhelm Röntgen in 1895, they have become a standard in medical imaging.
Motor proteins produce the forces required for crucial mechanical processes in the human body. On a nanometer scale—that is, a millionth of a millimeter—motor proteins, for instance, transport material within the human cells, or power the human muscles.
A cancer immunotherapy drug loaded onto a metal-organic framework exhibits improved delivery as well as a steady release for treating leukemia.